Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
SURMOUNT-1: Tirzepatide for Obesity The SURMOUNT-1 trial (NEJM, 2022) studied tirzepatide weight loss in 2,539 adults with obesity (without diabetes) over 72 weeks: STEP 1: Semaglutide for Obesity The STEP 1 trial (NEJM, 2021) studied semaglutide 2.4mg in 1,961 adults with obesity (without diabetes) over 68 weeks: Cross-Trial Summary Comparing across trials (with the caveat that indirect comparison has limitations): tirzepatide 15mg produced about 6 percentage points more weight loss than semaglutide 2.4mg over similar timeframes
Can someone below those BMI cutoffs still be a candidate
Psychiatry 14 , 1153648 (2023)
Murata, Effects of antidiabetic drugs on muscle mass in type 2 diabetes mellitus
Enjoyable gummy format made for consistent daily use
US$ 23.71
US$ 21.24
US$ 29.04
US$ 22.54
US$ 29.60
US$ 22.66
/assets/images/provider/photos/2773575.png)
